Scholar Rock Holding (SRRK) Other Working Capital Changes (2017 - 2026)
Scholar Rock Holding (SRRK) recorded quarterly Other Working Capital Changes of -$1.4 million in Q1 2026, down 117.57% quarter-over-quarter from $8.2 million in Q4 2025, and up 8.56% on a YoY basis from -$1.3 million in Q1 2025.
Scholar Rock Holding (SRRK) Other Working Capital Changes (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Other Working Capital Changes history runs 10 years deep, the most recent figure standing at -$1.4 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 8.56% year-over-year to -$1.4 million; the TTM figure through Mar 2026 stood at $3.8 million (up 148.69% YoY), while the FY2025 annual figure was $3.7 million, up 158.95% from the prior year.
- Other Working Capital Changes was -$1.4 million for Q1 2026 at Scholar Rock Holding, down from $8.2 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $33.0 million in Q2 2022 to a low of -$33.2 million in Q1 2022.
- Historically, Other Working Capital Changes has averaged -$938470.6 across 5 years, with a median of -$1.4 million in 2026.
- Biggest YoY gain for Other Working Capital Changes was 637.79% in 2025; the steepest drop was 7614.29% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at $25.8 million in 2022, then slumped by 93.85% to $1.6 million in 2023, then tumbled by 196.22% to -$1.5 million in 2024, then surged by 637.79% to $8.2 million in 2025, then tumbled by 117.57% to -$1.4 million in 2026.
- The last three Other Working Capital Changes figures came in at -$1.4 million (Q1 2026), $8.2 million (Q4 2025), and -$4.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Scholar Rock Holding | 6.03 Bn | 5.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.44 Mn |
| Mar 31, 2026 | -1.44 Mn |
| Dec 31, 2025 | 8.21 Mn |
| Dec 31, 2025 | 8.21 Mn |
| Sep 30, 2025 | -4.57 Mn |
| Sep 30, 2025 | -4.57 Mn |
| Jun 30, 2025 | 1.64 Mn |
| Jun 30, 2025 | 1.64 Mn |
| Mar 31, 2025 | -1.58 Mn |
| Mar 31, 2025 | -1.58 Mn |
| Dec 31, 2024 | -1.53 Mn |
| Dec 31, 2024 | -1.53 Mn |
| Sep 30, 2024 | -5.27 Mn |
| Sep 30, 2024 | -5.27 Mn |
| Jun 30, 2024 | 505,000.00 |
| Jun 30, 2024 | 505,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Dec 31, 2023 | 1.59 Mn |
| Dec 31, 2023 | 1.59 Mn |